References
- 1. Centers for disease Control and Prevention. Why Are Childhood Vaccines So Important? 2018 [cited 2019]; Available from: https://www.cdc.gov/vaccines/vac-gen/howvpd.htm.
- 2. Pick AM, Sweet DC, Begley KJ. A review of pediatric bacterial meningitis. US Pharmacist. 2016;41(5):41-5.
- 3. Theodoridou MN, Vasilopoulou VA, Atsali EE, Pangalis AM, Mostrou GJ, Syriopoulou VP, et al. Meningitis registry of hospitalized cases in children: epidemiological patterns of acute bacterial meningitis throughout a 32-year period. BMC Infect Dis. 2007 Aug 30;7:101.
- 4. Agrawal S, Nadel S. Acute bacterial meningitis in infants and children: epidemiology and management. Paediatr Drugs. 2011 Dec 1;13(6):385-400.
- 5. de Jonge RC, van Furth AM, Wassenaar M, Gemke RJ, Terwee CB. Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies. BMC Infect Dis. 2010 Aug 5;10:232.
- 6. Sheldon L, Kaplan MD. Bacterial meningitis in children older than one month: Clinical features and diagnosis. UpToDate [cited 2019]; Available from: https://www.uptodate.com/contents/bacterial-meningitisin-children-older-than-one-month-clinical-features-and-diagnosis.
- 7. Tacon CL, Flower O. Diagnosis and management of bacterial meningitis in the paediatric population: a review. Emerg Med Int. 2012;2012:320309.
- 8. Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010 May;10(5):317-28.
- 9. Kulkarni G. A case report of acute pediatric bacterial meningitis due to the rare isolate, Pseudomonas putida. Neuroimmunology and Neuroinflammation. 2016;3:215-8.
- 10. Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010 Mar;14(3):e197-209.
- 11. Kaman A, Aydin-Teke T, Oz FN, Bayhan GI, Metin O, Gayretli-Aydin ZG, et al. A pediatric case of acute meningitis due to Streptococcus pneumoniae serotype 33D. Turk J Pediatr. 2015 May-Jun;57(3):304-7.
- 12. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000 Mar;19(3):187-95.
- 13. Esposito S, Principi N. Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in Children. J Immunol Res. 2015;2015:591580.
- 14. Levy C, Varon E, Picard C, et al. Trends of pneumococcal meningitis in children after introduction of the 13-valent pneumococcal conjugate vaccine in France. Pediatr Infect Dis J. 2014; 33(12): 1216-21.
- 15. Cerri C, Caleo M, Bozzi Y. Chemokines as new inflammatory players in the pathogenesis of epilepsy. Epilepsy Res. 2017 Oct;136:77-83.
- 16. Kim KS. Acute bacterial meningitis in infants and children. Lancet Infect Dis. 2010 Jan;10(1):32-42.
- 17. Maiden MC, Ibarz-Pavon AB, Urwin R, Gray SJ, Andrews NJ, Clarke SC, et al. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis. 2008 Mar 1;197(5):737-43.
- 18. Sigurdardottir ST, Davidsdottir K, Arason VA, Jonsdottir O, Laudat F, Gruber WC, et al. Safety and immunogenicity of CRM197-conjugated pneumococcal-meningococcal C combination vaccine (9vPnC-MnCC) whether given in two or three primary doses. Vaccine. 2008 Aug 5;26(33):4178-86.
- 19. Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015 Sep 12(9):CD004405.
- 20. Ahmed AS, Khan NZ, Hussain M, Amin MR, Hanif M, Mahbub M, et al. Follow-up of cases of Haemophilus influenzae type b meningitis to determine its long-term sequelae. J Pediatr. 2013 Jul;163(1 Suppl):S44-9.
- 21. Forgie IM, O’Neill KP, Lloyd-Evans N, Leinonen M, Campbell H, Whittle HC, et al. Etiology of acute lower respiratory tract infections in Gambian children: I. Acute lower respiratory tract infections in infants presenting at the hospital. Pediatr Infect Dis J. 1991 Jan;10(1):33-41.
- 22. Forgie IM, O’Neill KP, Lloyd-Evans N, Leinonen M, Campbell H, Whittle HC, et al. Etiology of acute lower respiratory tract infections in Gambian children: II. Acute lower respiratory tract infection in children ages one to nine years presenting at the hospital. Pediatr Infect Dis J. 1991 Jan;10(1):42-7.
- 23. Shann F, Gratten M, Germer S, Linnemann V, Hazlett D, Payne R. Aetiology of pneumonia in children in Goroka Hospital, Papua New Guinea. Lancet. 1984 Sep 8;2(8402):537-41.
- 24. Saha SK, Rikitomi N, Ruhulamin M, Watanabe K, Ahmed K, Biswas D, et al. The increasing burden of disease in Bangladeshi children due to Haemophilus influenzae type b meningitis. Ann Trop Paediatr. 1997 Mar;17(1):5-8.
- 25. Watt JP, Levine OS, Santosham M. Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22-25, 2002. J Pediatr. 2003 Dec;143(6 Suppl):S163-87
- 26. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000 Apr;13(2):302-17.
- 27. World Health Organization. Haemophilus influenzae type b (Hib) 2019 [cited 2019]; Available from: http://www.euro.who.int/en/health-topics/disease-prevention/vaccinesand-immunization/vaccine-preventable-diseases/haemophilus-influenzae-type-b-hib.
- 28. Cowgill KD, Ndiritu M, Nyiro J, Slack MPE, Chiphatsi S, Ismail A, et al. Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA. 2006;296(6):671-8.
- 29. Lagos R, Horwitz I, Toro J, San Martin O, Abrego P, Bustamante C, et al. Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Pediatr Infect Dis J. 1996 Mar;15(3):216-22.
- 30. Murphy TV, White KE, Pastor P, Gabriel L, Medley F, Granoff DM, et al. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. Jama. 1993 Jan 13;269(2):246-8.
- 31. Urwin G, Yuan MF, Feldman RA. Prospective study of bacterial meningitis in North East Thames region, 1991-3, during introduction of Haemophilus influenzae vaccine. BMJ. 1994 Nov 26;309(6966):1412-4.
- 32. Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S, et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet. 2005 Jul 9-15;366(9480):144-50.